Predictors Of Benefits To Chemoimmunotherapy (Cit) In Stage Iv Non-Small-Cell Lung Cancer (Nsclc): A Meta-Analysis.

JOURNAL OF CLINICAL ONCOLOGY(2019)

引用 0|浏览9
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要